Top Markets
Coin of the day
Fischer Medical Ventures Ltd. Fischer Medical Ventures Ltd.

Fischer Medical Ventures Ltd.

FISCHER
Kedudukan dalam Saham #16873
Fischer Medical Ventures Limited, established in 1993 and headquartered in... Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Harga Saham
$0.4175976
Modal Pasaran
$273.32M
Perubahan (1 hari)
2.52%
Perubahan (1 tahun)
-65.44%
Negara
IN
Perdagangan Fischer Medical Ventures Ltd. (FISCHER)

Kategori

Pendapatan untuk Fischer Medical Ventures Ltd. (FISCHER)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Fischer Medical Ventures Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Fischer Medical Ventures Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US